# XCel Brands, Inc.: financial statements, quarterly

XELB · Nasdaq · CIK 1083220 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xelb.md) · [Financials](/companies/xelb/financials.md) · [Filings](/companies/xelb/filings.md) · [Insiders](/companies/xelb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/xelb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [2,637](/filings/0001558370-24-016432.md) | [2,287 d](/filings/0001558370-25-008172.md) | [2,184](/filings/0001558370-25-008402.md) | [2,954](/filings/0001558370-25-011582.md) | [1,912](/filings/0001104659-25-114198.md) | [1,209 d](/filings/0001104659-26-043348.md) | [1,332](/filings/0001104659-26-061185.md) | [1,321](/filings/0001104659-26-096016.md) | [1,118](/filings/0001104659-25-114198.md) | [1,168 d](/filings/0001104659-26-043348.md) | [1,144](/filings/0001104659-26-061185.md) | [1,121](/filings/0001104659-26-096016.md) |
| Cost of revenue | $k | [225](/filings/0001558370-24-016432.md) | [200 d](/filings/0001558370-25-008172.md) | not reported | [38.0](/filings/0001558370-25-011582.md) | [407](/filings/0001104659-25-114198.md) | [0.0 d](/filings/0001104659-26-043348.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $k | [2,412](/filings/0001558370-24-016432.md) | [2,087 d](/filings/0001558370-25-008172.md) | [2,184](/filings/0001558370-24-008490.md) | [2,916](/filings/0001558370-25-011582.md) | [1,505](/filings/0001104659-25-114198.md) | [1,209 d](/filings/0001104659-26-043348.md) | not reported | [1,321](/filings/0001558370-25-011582.md) | [1,118](/filings/0001104659-25-114198.md) | [1,168 d](/filings/0001104659-26-043348.md) | not reported | not reported |
| Selling, general and administrative | $k | [3,482](/filings/0001558370-24-016432.md) | [3,343 d](/filings/0001558370-25-008172.md) | [2,029](/filings/0001558370-25-008402.md) | [1,490](/filings/0001558370-25-011582.md) | [1,618](/filings/0001104659-25-114198.md) | [1,705 d](/filings/0001104659-26-043348.md) | [1,197](/filings/0001104659-26-061185.md) | [912](/filings/0001104659-26-096016.md) | [1,214](/filings/0001104659-25-114198.md) | [1,324 d](/filings/0001104659-26-043348.md) | [1,202](/filings/0001104659-26-061185.md) | [1,016](/filings/0001104659-26-096016.md) |
| Operating income | $k | [(5,403)](/filings/0001558370-24-016432.md) | [(5,620) d](/filings/0001558370-25-008172.md) | [(6,195)](/filings/0001558370-25-008402.md) | [307](/filings/0001558370-25-011582.md) | [(9,078)](/filings/0001104659-25-114198.md) | [(6,443) d](/filings/0001104659-26-043348.md) | [(2,187)](/filings/0001104659-26-061185.md) | [(1,654)](/filings/0001104659-26-096016.md) | [(7,442)](/filings/0001104659-25-114198.md) | [(1,948) d](/filings/0001104659-26-043348.md) | [(1,884)](/filings/0001104659-26-061185.md) | [(1,585)](/filings/0001104659-26-096016.md) |
| Interest expense | $k | not reported | not reported | [146](/filings/0001558370-25-008402.md) | [139](/filings/0001558370-25-011582.md) | [133](/filings/0001104659-25-114198.md) | [200 d](/filings/0001104659-26-043348.md) | [473](/filings/0001104659-26-061185.md) | [457](/filings/0001104659-26-096016.md) | [470](/filings/0001104659-25-114198.md) | [678 d](/filings/0001104659-26-043348.md) | [562](/filings/0001104659-26-061185.md) | [640](/filings/0001104659-26-096016.md) |
| Income tax | $k | [0.0](/filings/0001558370-24-016432.md) | [1,212 d](/filings/0001558370-25-008172.md) | [0.0](/filings/0001558370-25-008402.md) | [0.0](/filings/0001558370-25-011582.md) | [0.0](/filings/0001104659-25-114198.md) | [220 d](/filings/0001104659-26-043348.md) | [50.0](/filings/0001104659-26-061185.md) | [0.0](/filings/0001104659-26-096016.md) | [25.0](/filings/0001104659-25-114198.md) | [0.0 d](/filings/0001104659-26-043348.md) | [12.0](/filings/0001104659-26-061185.md) | [19.0](/filings/0001104659-26-096016.md) |
| Net income | $k | [(5,144)](/filings/0001558370-24-016432.md) | [(6,797) d](/filings/0001558370-25-008172.md) | [(6,294)](/filings/0001558370-25-008402.md) | [195](/filings/0001558370-25-011582.md) | [(9,213)](/filings/0001104659-25-114198.md) | [(7,083) d](/filings/0001104659-26-043348.md) | [(2,797)](/filings/0001104659-26-061185.md) | [(3,988)](/filings/0001104659-26-096016.md) | [(7,899)](/filings/0001104659-25-114198.md) | [(2,777) d](/filings/0001104659-26-043348.md) | [(2,489)](/filings/0001104659-26-061185.md) | [(2,476)](/filings/0001104659-26-096016.md) |
| Diluted EPS | $ per share | [(0.26)](/filings/0001558370-24-016432.md) | not reported | [(3.09)](/filings/0001558370-25-008402.md) | [0.08](/filings/0001558370-25-011582.md) | [(3.92)](/filings/0001104659-25-114198.md) | not reported | [(1.18)](/filings/0001104659-26-061185.md) | [(1.66)](/filings/0001104659-26-096016.md) | [(2.02)](/filings/0001104659-25-114198.md) | not reported | [(0.42)](/filings/0001104659-26-061185.md) | [(0.40)](/filings/0001104659-26-096016.md) |
| Basic EPS | $ per share | [(0.26)](/filings/0001558370-24-016432.md) | not reported | [(3.09)](/filings/0001558370-25-008402.md) | [0.08](/filings/0001558370-25-011582.md) | [(3.92)](/filings/0001104659-25-114198.md) | not reported | [(1.18)](/filings/0001104659-26-061185.md) | [(1.66)](/filings/0001104659-26-096016.md) | [(2.02)](/filings/0001104659-25-114198.md) | not reported | [(0.42)](/filings/0001104659-26-061185.md) | [(0.40)](/filings/0001104659-26-096016.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.2](/filings/0001558370-24-016432.md) | [3.0](/filings/0001558370-25-008172.md) | [1.6](/filings/0001558370-25-008402.md) | [0.9](/filings/0001558370-25-011582.md) | [0.2](/filings/0001104659-25-114198.md) | [1.3](/filings/0001104659-26-043348.md) | [0.3](/filings/0001104659-26-061185.md) | [1.0](/filings/0001104659-26-096016.md) | [1.5](/filings/0001104659-25-114198.md) | [1.2](/filings/0001104659-26-096016.md) | [0.2](/filings/0001104659-26-061185.md) | [0.4](/filings/0001104659-26-096016.md) |
| Current assets | $m | [8.4](/filings/0001558370-23-019258.md) | [7.3](/filings/0001558370-25-008172.md) | [6.1](/filings/0001558370-24-008490.md) | [4.8](/filings/0001558370-24-012121.md) | [3.5](/filings/0001558370-24-016432.md) | [4.0](/filings/0001104659-26-043348.md) | [2.9](/filings/0001558370-25-008402.md) | [3.2](/filings/0001558370-25-011582.md) | [4.1](/filings/0001104659-25-114198.md) | [3.7](/filings/0001104659-26-096016.md) | [4.5](/filings/0001104659-26-061185.md) | [1.5](/filings/0001104659-26-096016.md) |
| Total assets | $m | [75.8](/filings/0001558370-23-019258.md) | [71.7](/filings/0001558370-25-008172.md) | [66.8](/filings/0001558370-24-008490.md) | [63.2](/filings/0001558370-24-012121.md) | [54.0](/filings/0001558370-24-016432.md) | [53.8](/filings/0001104659-26-043348.md) | [52.5](/filings/0001558370-25-008402.md) | [47.2](/filings/0001558370-25-011582.md) | [40.5](/filings/0001104659-25-114198.md) | [38.9](/filings/0001104659-26-096016.md) | [36.4](/filings/0001104659-26-061185.md) | [32.5](/filings/0001104659-26-096016.md) |
| Current liabilities | $m | [6.7](/filings/0001558370-23-019258.md) | [6.5](/filings/0001558370-25-008172.md) | [6.2](/filings/0001558370-24-008490.md) | [6.1](/filings/0001558370-24-012121.md) | [6.8](/filings/0001558370-24-016432.md) | [10.4](/filings/0001104659-26-043348.md) | [10.5](/filings/0001558370-25-008402.md) | [5.5](/filings/0001558370-25-011582.md) | [8.0](/filings/0001104659-25-114198.md) | [7.5](/filings/0001104659-26-096016.md) | [7.7](/filings/0001104659-26-061185.md) | [5.5](/filings/0001104659-26-096016.md) |
| Total liabilities | $m | [20.4](/filings/0001558370-23-019258.md) | [23.5](/filings/0001558370-25-008172.md) | [22.9](/filings/0001558370-24-008490.md) | [19.1](/filings/0001558370-24-012121.md) | [19.0](/filings/0001558370-24-016432.md) | [25.4](/filings/0001104659-26-043348.md) | [26.8](/filings/0001558370-25-008402.md) | [24.7](/filings/0001558370-25-011582.md) | [23.9](/filings/0001104659-25-114198.md) | [23.1](/filings/0001104659-26-096016.md) | [23.2](/filings/0001104659-26-061185.md) | [20.8](/filings/0001104659-26-096016.md) |
| Long-term debt | $m | not reported | [4.0](/filings/0001558370-25-008172.md) | [3.7](/filings/0001558370-24-008490.md) | [3.5](/filings/0001558370-24-012121.md) | [3.3](/filings/0001558370-24-016432.md) | [6.6](/filings/0001104659-26-043348.md) | [8.5](/filings/0001558370-25-008402.md) | [11.8](/filings/0001558370-25-011582.md) | [9.0](/filings/0001104659-25-114198.md) | [9.5](/filings/0001104659-26-096016.md) | [9.8](/filings/0001104659-26-061185.md) | [10.2](/filings/0001104659-26-096016.md) |
| Current portion of debt | $m | not reported | [0.8](/filings/0001558370-25-008172.md) | [1.0](/filings/0001558370-24-008490.md) | [1.0](/filings/0001558370-24-012121.md) | [1.0](/filings/0001558370-24-016432.md) | not reported | [0.3](/filings/0001558370-25-008402.md) | [0.5](/filings/0001558370-25-011582.md) | [3.5](/filings/0001104659-25-114198.md) | [3.3](/filings/0001104659-26-096016.md) | [2.8](/filings/0001104659-26-061185.md) | [1.9](/filings/0001104659-26-096016.md) |
| Shareholders' equity | $m | [56.8](/filings/0001558370-23-019258.md) | [50.0](/filings/0001558370-25-008172.md) | [45.8](/filings/0001558370-24-008490.md) | [46.0](/filings/0001558370-24-012121.md) | [36.9](/filings/0001558370-24-016432.md) | [30.4](/filings/0001104659-26-043348.md) | [27.7](/filings/0001558370-25-008402.md) | [24.5](/filings/0001558370-25-011582.md) | [18.7](/filings/0001104659-25-114198.md) | [18.0](/filings/0001104659-26-096016.md) | [15.3](/filings/0001104659-26-061185.md) | [13.9](/filings/0001104659-26-096016.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,339) d](/filings/0001558370-24-016432.md) | [(3,735) d](/filings/0001558370-25-008172.md) | [(2,609)](/filings/0001558370-25-008402.md) | [(274) d](/filings/0001558370-25-011582.md) | [(424) d](/filings/0001104659-25-114198.md) | [(1,409) d](/filings/0001104659-26-043348.md) | [(1,434)](/filings/0001104659-26-061185.md) | [(2,364) d](/filings/0001104659-26-096016.md) | [(1,398) d](/filings/0001104659-25-114198.md) | [(1,827) d](/filings/0001104659-26-043348.md) | [(877)](/filings/0001104659-26-061185.md) | [(1,855) d](/filings/0001104659-26-096016.md) |
| Capital expenditure | $k | [6.0 d](/filings/0001558370-24-016432.md) | [13.0 d](/filings/0001558370-25-008172.md) | not reported | not reported | [8.0 d](/filings/0001104659-25-114198.md) | [0.0 d](/filings/0001104659-26-043348.md) | [14.0](/filings/0001104659-26-061185.md) | [(4.0) d](/filings/0001104659-26-096016.md) | [0.0 d](/filings/0001104659-25-114198.md) | [0.0 d](/filings/0001104659-26-043348.md) | not reported | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | [58.0](/filings/0001104659-26-061185.md) | [58.0 d](/filings/0001104659-26-096016.md) | [6.0 d](/filings/0001104659-25-114198.md) | [82.0 d](/filings/0001104659-26-043348.md) | [46.0](/filings/0001104659-26-061185.md) | [56.0 d](/filings/0001104659-26-096016.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [19.6](/filings/0001558370-23-019258.md) | [19.6](/filings/0001558370-24-008490.md) | [19.7](/filings/0001558370-24-012121.md) | [19.7](/filings/0001558370-24-016432.md) | [2.0](/filings/0001558370-25-008402.md) | [2.4](/filings/0001558370-25-011582.md) | [2.4](/filings/0001104659-25-114198.md) | [2.4](/filings/0001104659-26-061185.md) | [2.4](/filings/0001104659-26-096016.md) | [3.9](/filings/0001104659-25-114198.md) | [5.9](/filings/0001104659-26-061185.md) | [6.2](/filings/0001104659-26-096016.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,560,274 at 2026-08-02, from the cover of the [10-Q filed 2026-08-13](/filings/0001104659-26-096016.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.